Recent advances in understanding pathogenesis and therapeutic strategies of Systemic Lupus Erythematosus
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in understanding pathogenesis and therapeutic strategies of Systemic Lupus Erythematosus
Authors
Keywords
Systemic lupus erythematosus, Pathogenesis, Therapeutic strategies, Biological agents, Clinical trials
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 89, Issue -, Pages 107028
Publisher
Elsevier BV
Online
2020-10-09
DOI
10.1016/j.intimp.2020.107028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus
- (2020) Sonja Hartmann et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Pim-1 as a therapeutic target in human lupus nephritis
- (2019) Rong Fu et al. Arthritis & Rheumatology
- Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
- (2019) Richard Furie et al. JOURNAL OF CLINICAL INVESTIGATION
- Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal
- (2019) Doua Azzouz et al. ANNALS OF THE RHEUMATIC DISEASES
- Therapeutic advances in the treatment of SLE
- (2019) Ali Mohamed et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Novel paradigms in systemic lupus erythematosus
- (2019) Thomas Dörner et al. LANCET
- Epigenetic programming underpins B cell dysfunction in human SLE
- (2019) Christopher D. Scharer et al. NATURE IMMUNOLOGY
- FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding
- (2019) Wei Hu et al. eLife
- Current mechanistic insights into the role of infection in systemic lupus erythematosus
- (2019) Qingjun Pan et al. BIOMEDICINE & PHARMACOTHERAPY
- Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases
- (2019) Sarah Y. Weißenberg et al. Frontiers in Immunology
- Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial
- (2019) Alexis Mathian et al. ANNALS OF THE RHEUMATIC DISEASES
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
- (2019) Xue Han et al. Science Translational Medicine
- The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry
- (2018) George N. Goulielmos et al. GENE
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- Role of Bruton’s tyrosine kinase in B cells and malignancies
- (2018) Simar Pal Singh et al. Molecular Cancer
- Translocation of a gut pathobiont drives autoimmunity in mice and humans
- (2018) S. Manfredo Vieira et al. SCIENCE
- Lupus-An Unrecognized Leading Cause of Death in Young Females: A Population-Based Study Using Nationwide Death Certificates, 2000-2015
- (2018) Eric Y. Yen et al. Arthritis & Rheumatology
- An evaluation of voclosporin for the treatment of lupus nephritis
- (2018) Fang En Sin et al. EXPERT OPINION ON PHARMACOTHERAPY
- A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans
- (2018) Konstantinos Biliouris et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Bruton’s tyrosine kinase inhibitors in B-cell lymphoma: current experience and future perspectives
- (2017) T. Seiler et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy of baricitinib in the treatment of rheumatoid arthritis
- (2017) Christophe Richez et al. EXPERT OPINION ON PHARMACOTHERAPY
- Potential applications of Bruton’s tyrosine kinase inhibitors for the prevention of allergic reactions
- (2017) Melanie C. Dispenza et al. Expert Review of Clinical Immunology
- Bim suppresses the development of SLE by limiting myeloid inflammatory responses
- (2017) FuNien Tsai et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
- (2017) Robert Marcus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status
- (2017) Jôice Dias Corrêa et al. Microbiome
- Control of lupus nephritis by changes of gut microbiota
- (2017) Qinghui Mu et al. Microbiome
- Antibiotics ameliorate lupus-like symptoms in mice
- (2017) Qinghui Mu et al. Scientific Reports
- The microbiota in adaptive immune homeostasis and disease
- (2016) Kenya Honda et al. NATURE
- New insights into the immunopathogenesis of systemic lupus erythematosus
- (2016) George C. Tsokos et al. Nature Reviews Rheumatology
- Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients
- (2016) Patricia López et al. Scientific Reports
- FcγRIIB and autoimmunity
- (2015) Marion Espéli et al. IMMUNOLOGICAL REVIEWS
- Targeting Antigens through Blood Dendritic Cell Antigen 2 on Plasmacytoid Dendritic Cells Promotes Immunologic Tolerance
- (2014) C. P. Chappell et al. JOURNAL OF IMMUNOLOGY
- FCGR2B and FCRLB Gene Polymorphisms Associated with IgA Nephropathy
- (2013) Xu-jie Zhou et al. PLoS One
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- TheFCGR2Brs10917661 polymorphism may confer susceptibility to ankylosing spondylitis in Han Chinese: a case–control study
- (2012) Z-H Duan et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- FcγRIIB, FcγRIIIB, and systemic lupus erythematosus
- (2010) Heather A. Niederer et al. Annals of the New York Academy of Sciences
- Apoptosis Regulators Bim and Fas Function Concurrently to Control Autoimmunity and CD8+ T Cell Contraction
- (2008) Ashley E. Weant et al. IMMUNITY
- Combined Deficiency of Proapoptotic Regulators Bim and Fas Results in the Early Onset of Systemic Autoimmunity
- (2008) Jack Hutcheson et al. IMMUNITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now